DO WE HAVE TO CHELATE PATIENTS WITH THALASEMIA MAJOR HAVING FERRITIN LEVELS < 500 MG/L?

dc.contributor.author	Aycicek, A.
dc.contributor.author	Bayram, C.
dc.contributor.author	Gokce, M.
dc.contributor.author	Keskindemirci, Gonca
dc.contributor.author	Ayaz, Nuray
dc.contributor.author	Aydogan, G.
dc.contributor.author	Salcioglu, Z.
dc.contributor.author	Akici, F.
dc.contributor.author	Sen, H.
dc.contributor.author	Tugcu, Deniz
dc.date.accessioned	2021-03-04T18:26:19Z
dc.date.available	2021-03-04T18:26:19Z
dc.identifier.citation	Aydogan G., Salcioglu Z., Akici F., Sen H., Tugcu D., Gokce M., Aycicek A., Keskindemirci G., Ayaz N., Bayram C., "DO WE HAVE TO CHELATE PATIENTS WITH THALASEMIA MAJOR HAVING FERRITIN LEVELS < 500 MG/L?", 20th Congress of European-Hematology-Association, Vienna, Avusturya, 11 - 14 Haziran 2015, cilt.100, ss.599
dc.identifier.other	av_8aa747e9-0dab-46e9-be5d-02455fba75fb
dc.identifier.other	vv_1032021
dc.identifier.uri	http://hdl.handle.net/20.500.12627/93967
dc.language.iso	eng
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Hematoloji
dc.subject	Klinik Tıp (MED)
dc.subject	Klinik Tıp
dc.subject	Tıp
dc.subject	HEMATOLOJİ
dc.title	DO WE HAVE TO CHELATE PATIENTS WITH THALASEMIA MAJOR HAVING FERRITIN LEVELS < 500 MG/L?
dc.type	Bildiri
dc.contributor.department	Istanbul Kanuni Sultan Suleyman Training & Research Hospital , ,
dc.identifier.volume	100
dc.contributor.firstauthorID	2219329

Files in this item

Files	Size	Format	View
There are no files associated with this item.